Literature DB >> 31226295

Disparities in healthcare services in women with endometriosis with public vs private health insurance.

Jessica Fourquet1, Diego E Zavala1, Stacey Missmer2, Nabal Bracero3, Josefina Romaguera3, Idhaliz Flores4.   

Abstract

BACKGROUND: The goals of health disparities research are to identify facilitators and barriers to healthcare use to help eliminate health inequalities. There are few studies on disparities in healthcare access and use trends for patients with endometriosis that may lead to differences in appropriate care based on socioeconomic status.
OBJECTIVE: This retrospective, cross-sectional study was conducted to compare health services use patterns and prevalence of co-morbidities of women with endometriosis with public (government-based) vs private (purchased or provided by employer) health insurance. STUDY
DESIGN: A total of 342 deidentified datasets (171 randomly-selected cases per study group) from women with endometriosis 14-50 years old who were members of one health insurance company that provides both public and private health insurance coverage in Puerto Rico were analyzed. Patients were defined as having at least 1 endometriosis-related medical claim (ICD-9-617.xx; International Classification of Diseases, Ninth Revision, Clinical Modification) during the 3-year study period.
RESULTS: Medical service (eg, hospital, laboratory, pathology, and radiology) use trends were 3 times lower in the public vs the private sector. Women in the public sector were 3.5 times less likely to have a laparoscopy, 2.7 times more likely to be prescribed opioid/narcotics, and were the only study subjects reporting emergency department use. Obstetrics and gynecology services were used >2-fold less by women in the public (29.5%) vs the private sector (70.5%) (P=.087).
CONCLUSIONS: We report significant differences in the use trends of endometriosis-related medical services and prescriptions, indicating differences in healthcare access based on socioeconomic parameters. Our results support the development of public health programs to promote access to healthcare for patients with endometriosis irrespective of socioeconomic status and promote health disparity research in other healthcare systems.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  access to care; endometriosis; health disparities; health economics; medical claims

Year:  2019        PMID: 31226295     DOI: 10.1016/j.ajog.2019.06.020

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Associations between physical exercise patterns and pain symptoms in individuals with endometriosis: a cross-sectional mHealth-based investigation.

Authors:  Ipek Ensari; Sharon Lipsky-Gorman; Emma N Horan; Suzanne Bakken; Noémie Elhadad
Journal:  BMJ Open       Date:  2022-07-18       Impact factor: 3.006

2.  Analysis of the Relationship between Socioeconomic Status and Incidence of Hysterectomy Using Data of the Korean Genome and Epidemiology Study (KoGES).

Authors:  Yung-Taek Ouh; Kyung-Jin Min; Sanghoon Lee; Jin-Hwa Hong; Jae Yun Song; Jae-Kwan Lee; Nak Woo Lee
Journal:  Healthcare (Basel)       Date:  2022-05-27

3.  Augmenting the Clinical Data Sources for Enigmatic Diseases: A Cross-Sectional Study of Self-Tracking Data and Clinical Documentation in Endometriosis.

Authors:  Ipek Ensari; Adrienne Pichon; Sharon Lipsky-Gorman; Suzanne Bakken; Noémie Elhadad
Journal:  Appl Clin Inform       Date:  2020-11-18       Impact factor: 2.342

4.  Outcomes for Patients with Sepsis Following Admission to the Intensive Care Unit Based on Health Insurance Status: A Study from the Medical Information Mart for Intensive Care-III (MIMIC-III) Database.

Authors:  Ying Zhou; Di Yang; Qiang Fu; Tao Chen; Yong Chen; Chuandong Zheng
Journal:  Med Sci Monit       Date:  2020-09-16

5.  Inquiry into women's pathways to diagnosis of endometriosis: A qualitative study protocol.

Authors:  Martha G Cromeens; Suzanne Thoyre; Erin T Carey; Kathleen Knafl; Whitney R Robinson
Journal:  J Adv Nurs       Date:  2020-10-27       Impact factor: 3.187

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.